IAIM
AQST icon

International Assets Investment Management’s Aquestive Therapeutics AQST Stock Holding History

International Assets Investment Management’s Portfolio AQST Stock Details AQST Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$91.6K Sell
21,595
-1,300
-6% -$5.47K 0.01% 1121
2026
Q1 		$94.6K Buy
22,895
+4,870
+27% +$19.8K 0.01% 1030
2025
Q4 		$116K Buy
18,025
+475
+3% +$2.96K 0.01% 969
2025
Q3 		$59.7K Buy
+17,550
New +$75.9K ﹤0.01% 804
2024
Q4 		– Sell
-19,920
Closed -$4K – 889
2024
Q3 		$4K Buy
+19,920
New +$77.5K 0.01% 633

Other funds holding AQST

WA
Wasatch Advisors Salt Lake City, Utah $15.3B AUM 25.06% 1-Year Est. Return
Commonwealth Equity Services
Commonwealth Equity Services Waltham, Massachusetts $79.5B AUM 27.1% 1-Year Est. Return
SAM
Simplify Asset Management Las Vegas, Nevada $7.19B AUM 6.88% 1-Year Est. Return
SMAM
Sugar Maple Asset Management Sister Bay, Wisconsin $155M AUM 17.72% 1-Year Est. Return
PM
Penbrook Management New York $157M AUM 46.57% 1-Year Est. Return
DWP
Daymark Wealth Partners Cincinnati, Ohio $4.1B AUM 28.59% 1-Year Est. Return
SWRP
Summit Wealth & Retirement Planning San Ramon, California $472M AUM 25.49% 1-Year Est. Return
Cambridge Investment Research Advisors
Cambridge Investment Research Advisors Fairfield, Iowa $44.6B AUM 28.94% 1-Year Est. Return
PFSRSONJ
Police & Firemen's Retirement System of New Jersey Trenton, New Jersey $13.3B AUM 45.46% 1-Year Est. Return
New York State Common Retirement Fund
New York State Common Retirement Fund Albany, New York $79.3B AUM 43.63% 1-Year Est. Return

International Assets Investment Management's AQST Position: Q2 2026 in Review

International Assets Investment Management reduced its Aquestive Therapeutics (AQST) stake by 5.7% in Q2 2026, selling an estimated $5.47K and leaving 21,595 shares worth $91.6K. The position accounts for 0.01% of the portfolio, ranked #1121.

International Assets Investment Management first reported a position in AQST in Q3 2024 and has held it in 5 quarters since. The position peaked at $116K in Q4 2025. 34 funds tracked by Wall St. Rank hold AQST as of Q2 2026.

  • International Assets Investment Management held 21,595 shares of Aquestive Therapeutics worth $91.6K as of Q2 2026.
  • International Assets Investment Management sold 1,300 Aquestive Therapeutics shares in Q2 2026, an estimated $5.47K.
  • Aquestive Therapeutics made up 0.01% of International Assets Investment Management's portfolio in Q2 2026, its #1121 holding.
  • International Assets Investment Management first reported a position in Aquestive Therapeutics in Q3 2024 and has held it in 5 quarters since.
  • International Assets Investment Management's Aquestive Therapeutics position peaked at $116K in Q4 2025.
  • 34 funds tracked by Wall St. Rank held Aquestive Therapeutics as of Q2 2026.

Based on International Assets Investment Management's 13F filing for Q2 2026, filed 22 Jul 2026.